发明申请
US20070212370A1 Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
有权
可溶性CD83蛋白及其用于治疗和预防由涉及T细胞的细胞免疫应答的功能障碍或不期望功能引起的疾病或医学病症
- 专利标题： Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
- 专利标题（中）： 可溶性CD83蛋白及其用于治疗和预防由涉及T细胞的细胞免疫应答的功能障碍或不期望功能引起的疾病或医学病症
-
申请号： US11699918申请日： 2007-01-30
-
公开(公告)号： US20070212370A1公开(公告)日： 2007-09-13
- 发明人: Alexander Steinkasserer , Matthias Lechmann , Elisabeth Zinser
- 申请人： Alexander Steinkasserer , Matthias Lechmann , Elisabeth Zinser
- 申请人地址： US NC Durham
- 专利权人： ARGOS THERAPEUTICS INC
- 当前专利权人： ARGOS THERAPEUTICS INC
- 当前专利权人地址： US NC Durham
- 主分类号： A61K39/00
- IPC分类号： A61K39/00 ; A61K31/7052 ; A61K39/15 ; C12N15/00 ; C12P1/04 ; G01N33/574 ; C12N5/06 ; C07K14/00 ; A61K38/00
摘要：
The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving T cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
公开/授权文献
信息查询
